Phase II Trial of GW572016 in Patients With Recurrent Prostate Cancer as Evident By a Rising PSA.
Phase of Trial: Phase II
Latest Information Update: 18 Mar 2015
At a glance
- Drugs Lapatinib (Primary)
- Indications Prostate cancer
- Focus Biomarker; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 12 Apr 2012 Actual end date (July 2009) added as reported by ClinicalTrials.gov.
- 22 Mar 2010 Status changed from active, no longer recruiting to completed.